AISLABIE BLOODSTOCK LIMITED

Company Registration Number:
06314676 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2024

Period of accounts

Start date: 01 January 2024

End date: 31 December 2024

AISLABIE BLOODSTOCK LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2024

Balance sheet
Notes

AISLABIE BLOODSTOCK LIMITED

Balance sheet

As at 31 December 2024


Notes

2024

2023


£

£
Fixed assets
Tangible assets: 3 1,555,606 1,452,350
Total fixed assets: 1,555,606 1,452,350
Current assets
Stocks: 2,549,750 2,277,000
Debtors:   603,803 145,061
Cash at bank and in hand: 38,306 16,489
Total current assets: 3,191,859 2,438,550
Creditors: amounts falling due within one year:   (18,427,379) (16,800,378)
Net current assets (liabilities): (15,235,520) (14,361,828)
Total assets less current liabilities: (13,679,914) (12,909,478)
Total net assets (liabilities): (13,679,914) (12,909,478)
Capital and reserves
Called up share capital: 100 100
Profit and loss account: (13,680,014) (12,909,578)
Shareholders funds: (13,679,914) (12,909,478)

The notes form part of these financial statements

AISLABIE BLOODSTOCK LIMITED

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 21 May 2025
and signed on behalf of the board by:

Name: F Nass
Status: Director

The notes form part of these financial statements

AISLABIE BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

AISLABIE BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

2. Employees

2024 2023
Average number of employees during the period 12 12

AISLABIE BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Tangible Assets

Total
Cost £
At 01 January 2024 1,976,035
Additions 430,346
Disposals (374,742)
At 31 December 2024 2,031,639
Depreciation
At 01 January 2024 523,685
Charge for year 83,590
On disposals (131,242)
At 31 December 2024 476,033
Net book value
At 31 December 2024 1,555,606
At 31 December 2023 1,452,350